Literature DB >> 8990194

A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators.

T N Collingwood1, O Rajanayagam, M Adams, R Wagner, V Cavaillès, E Kalkhoven, C Matthews, E Nystrom, K Stenlof, G Lindstedt, L Tisell, R J Fletterick, M G Parker, V K Chatterjee.   

Abstract

The syndrome of resistance to thyroid hormone is characterized by elevated serum free thyroid hormones, failure to suppress pituitary thyrotropin secretion, and variable peripheral refractoriness to hormone action. Here we describe a novel leucine to valine mutation in codon 454 (L454V) of the thyroid hormone beta receptor (TR beta) in this disorder, resulting in a mutant receptor with unusual functional properties. Although the mutant protein binds ligand comparably to wild-type receptor and forms homo- and heterodimers on direct repeat, everted repeat, or palindromic thyroid response elements, its ability to activate transcription via these elements is markedly impaired. The hydrophobic leucine residue lies within an amphipathic alpha-helix at the carboxyl terminus of TR beta and the position of the homologous residue in the crystal structure of TR alpha indicates that its side chain is solvent-exposed and might interact with other proteins. We find that two putative transcriptional mediators (RIP140 and SRC-1) exhibit hormone-dependent association with wild-type TR. In comparison, the interaction of this natural mutant (L454V) and artificial mutants (L454A, E457A) with RIP140 and SRC-1 is markedly reduced. Furthermore, coexpression of SRC-1 is able to restore the transcriptional activity of the L454V mutant receptor, indicating that the interaction of this residue with accessory proteins is critical for transcriptional activation. Finally, the occurrence of the L454V mutation in resistance to thyroid hormone, together with impaired negative regulation of the thyroid-stimulating hormone alpha promoter by this mutant, suggests that the amphipathic alpha-helix also mediates hormone-dependent transcriptional inhibition, perhaps via interaction with these or other accessory factors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8990194      PMCID: PMC19304          DOI: 10.1073/pnas.94.1.248

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid.

Authors:  J P Renaud; N Rochel; M Ruff; V Vivat; P Chambon; H Gronemeyer; D Moras
Journal:  Nature       Date:  1995-12-14       Impact factor: 49.962

2.  A structural role for hormone in the thyroid hormone receptor.

Authors:  R L Wagner; J W Apriletti; M E McGrath; B L West; J D Baxter; R J Fletterick
Journal:  Nature       Date:  1995-12-14       Impact factor: 49.962

3.  Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding.

Authors:  R Kurokawa; J DiRenzo; M Boehm; J Sugarman; B Gloss; M G Rosenfeld; R A Heyman; C K Glass
Journal:  Nature       Date:  1994-10-06       Impact factor: 49.962

4.  Interaction of thyroid-hormone receptor with a conserved transcriptional mediator.

Authors:  J W Lee; F Ryan; J C Swaffield; S A Johnston; D D Moore
Journal:  Nature       Date:  1995-03-02       Impact factor: 49.962

5.  Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone beta-receptors in thyroid hormone resistance syndrome.

Authors:  T N Collingwood; M Adams; Y Tone; V K Chatterjee
Journal:  Mol Endocrinol       Date:  1994-09

6.  Mouse retinoid X receptor contains a separable ligand-binding and transactivation domain in its E region.

Authors:  X Leng; J Blanco; S Y Tsai; K Ozato; B W O'Malley; M J Tsai
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

7.  Sequence and characterization of a coactivator for the steroid hormone receptor superfamily.

Authors:  S A Oñate; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

8.  A novel C-terminal domain in the thyroid hormone receptor selectively mediates thyroid hormone inhibition.

Authors:  T R Flynn; A N Hollenberg; O Cohen; J B Menke; S J Usala; S Tollin; M K Hegarty; F E Wondisford
Journal:  J Biol Chem       Date:  1994-12-30       Impact factor: 5.157

9.  The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18.

Authors:  B Le Douarin; C Zechel; J M Garnier; Y Lutz; L Tora; P Pierrat; D Heery; H Gronemeyer; P Chambon; R Losson
Journal:  EMBO J       Date:  1995-05-01       Impact factor: 11.598

10.  Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor.

Authors:  V Cavaillès; S Dauvois; F L'Horset; G Lopez; S Hoare; P J Kushner; M G Parker
Journal:  EMBO J       Date:  1995-08-01       Impact factor: 11.598

View more
  19 in total

1.  A dominant negative PPARgamma mutant shows altered cofactor recruitment and inhibits adipogenesis in 3T3-L1 cells.

Authors:  Y Park; B D Freedman; E J Lee; S Park; J L Jameson
Journal:  Diabetologia       Date:  2003-03-07       Impact factor: 10.122

2.  Structure and specificity of nuclear receptor-coactivator interactions.

Authors:  B D Darimont; R L Wagner; J W Apriletti; M R Stallcup; P J Kushner; J D Baxter; R J Fletterick; K R Yamamoto
Journal:  Genes Dev       Date:  1998-11-01       Impact factor: 11.361

3.  A role for helix 3 of the TRbeta ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone.

Authors:  T N Collingwood; R Wagner; C H Matthews; R J Clifton-Bligh; M Gurnell; O Rajanayagam; M Agostini; R J Fletterick; P Beck-Peccoz; W Reinhardt; G Binder; M B Ranke; A Hermus; R D Hesch; J Lazarus; P Newrick; V Parfitt; P Raggatt; F de Zegher; V K Chatterjee
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

4.  Natural products reveal cancer cell dependence on oxysterol-binding proteins.

Authors:  Anthony W G Burgett; Thomas B Poulsen; Kittikhun Wangkanont; D Ryan Anderson; Chikako Kikuchi; Kousei Shimada; Shuichi Okubo; Kevin C Fortner; Yoshihiro Mimaki; Minpei Kuroda; Jason P Murphy; David J Schwalb; Eugene C Petrella; Ivan Cornella-Taracido; Markus Schirle; John A Tallarico; Matthew D Shair
Journal:  Nat Chem Biol       Date:  2011-08-07       Impact factor: 15.040

5.  Pathogenic mechanism of mutations in the thyroid hormone receptor β gene.

Authors:  S Pongjantarasatian; S Wacharasindhu; S Tongkobpetch; K Suphapeetiporn; V Shotelersuk
Journal:  J Endocrinol Invest       Date:  2011-07-27       Impact factor: 4.256

Review 6.  Mutational Landscape of Resistance to Thyroid Hormone Beta (RTHβ).

Authors:  Paola Concolino; Alessandra Costella; Rosa Maria Paragliola
Journal:  Mol Diagn Ther       Date:  2019-06       Impact factor: 4.074

7.  Differential recognition of liganded and unliganded thyroid hormone receptor by retinoid X receptor regulates transcriptional repression.

Authors:  J Zhang; I Zamir; M A Lazar
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

8.  Negative regulation by thyroid hormone receptor requires an intact coactivator-binding surface.

Authors:  Tania M Ortiga-Carvalho; Nobuyuki Shibusawa; Amisra Nikrodhanond; Karen J Oliveira; Danielle S Machado; Xiao-Hui Liao; Ronald N Cohen; Samuel Refetoff; Fredric E Wondisford
Journal:  J Clin Invest       Date:  2005-08-11       Impact factor: 14.808

9.  A novel 1297-1304delGCCTGCCA mutation in the exon 10 of the thyroid hormone receptor β gene causes resistance to thyroid hormone.

Authors:  Carina M Rivolta; M Susana Mallea Gil; Carolina Ballarino; M Carolina Ridruejo; Carlos M Miguel; Silvia B Gimenez; Silvia S Bernacchi; Héctor M Targovnik
Journal:  Mol Diagn       Date:  2004-09

10.  In vivo interaction of steroid receptor coactivator (SRC)-1 and the activation function-2 domain of the thyroid hormone receptor (TR) beta in TRbeta E457A knock-in and SRC-1 knockout mice.

Authors:  Manuela Alonso; Charles Goodwin; Xiaohui Liao; Tania Ortiga-Carvalho; Danielle S Machado; Fredric E Wondisford; Samuel Refetoff; Roy E Weiss
Journal:  Endocrinology       Date:  2009-04-30       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.